{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-014058","form_type":"8-K","ticker":"AMS","cik":"0000744825","company_name":"AMERICAN SHARED HOSPITAL SERVICES","filed_at":"2023-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.140535+00:00","generated_at":"2026-06-15T03:05:16.628539+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AMS reports Q1 net income of $188K ($0.03 EPS), down 30% YoY; revenue +1.6%","bullets":["Total revenue $4.925M (+1.6% YoY); gross margin fell to 38.7% from 42.6%.","Operating income $98K, down 83.7% from $600K; selling & admin costs up 16.7%.","Appointed Robert Hiatt as new CFO; second order of 2023 for Gamma Knife Esprit upgrade.","Approved upgrades in Ecuador and Mexico; start-up expected Q3 2023. Cash $13.2M.","Adjusted EBITDA $1.903M vs $1.922M; Gamma Knife procedures down 10.9%."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-014058","json":"https://secwatch.observer/filing/0001437749-23-014058.json","markdown":"https://secwatch.observer/filing/0001437749-23-014058.md","text":"https://secwatch.observer/filing/0001437749-23-014058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744825/000143774923014058/0001437749-23-014058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744825/000143774923014058/asha20230511_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T03:05:16.628539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7cc7d469e68e59fb079f674e403914405a4bf392","claim":"AMERICAN SHARED HOSPITAL SERVICES reported first quarter ended March 31, 2023 results: revenue $4,925,000, net income $188,000, EPS $0.03 per diluted share.","evidence_excerpt":"First Quarter 2023 Highlights ● Total revenue in the first quarter was $4,925,000, an increase of 1.6% from the comparable period in 2022. Total proton therapy revenue increased 13.5% period-over-period; fractions decreased 5.7%. ● Gross margin was $1,908,000, a period-over-period decrease of 7.7%. The gross margin percentage was 38.7% of revenue. ● Operating income for the first quarter of 2023 was $98,000 compared to operating income of $600,000 in the first quarter of 2022, a decrease of 83.7%. ● Net income attributable to American Shared Hospital Services in the first quarter was $188,000, or $0.03 per diluted share, compared to net income of $269,000, or $0.04 per diluted share, for the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744825/000143774923014058/0001437749-23-014058-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$4,925,000"},{"label":"Net income","value":"$188,000"},{"label":"EPS","value":"$0.03 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}